Albertini Richard, Clewell Harvey, Himmelstein Matthew W, Morinello Eric, Olin Stephen, Preston Julian, Scarano Louis, Smith Martyn T, Swenberg James, Tice Raymond, Travis Curtis
University of Vermont, Burlington, VT 05401, USA.
Regul Toxicol Pharmacol. 2003 Feb;37(1):105-32. doi: 10.1016/s0273-2300(02)00019-3.
The estimation and characterization of a cancer risk is grounded in the observation of tumors in humans and/or experimental animals. Increasingly, however, other kinds of data (non-tumor data) are finding application in cancer risk assessment. Metabolism and kinetics, adduct formation, genetic damage, mode of action, and biomarkers of exposure, susceptibility, and effects are examples. While these and other parameters have been studied for many important chemicals over the past 30-40 years, their use in risk assessments is more recent, and new insights and opportunities are continuing to unfold. To provide some perspective on this field, the ILSI Risk Science Institute asked a select working group to characterize the pertinent non-tumor data available for 1,3-butadiene, benzene, and vinyl chloride and to comment on the utility of these data in characterizing cancer risks. This paper presents the findings of that working group and concludes with 15 simple principles for the use of non-tumor data in cancer risk assessment.
癌症风险的评估与特征描述基于对人类和/或实验动物肿瘤的观察。然而,其他类型的数据(非肿瘤数据)在癌症风险评估中的应用越来越多。代谢与动力学、加合物形成、遗传损伤、作用模式以及暴露、易感性和效应的生物标志物等都是例子。尽管在过去30至40年里,已经对许多重要化学物质的这些及其他参数进行了研究,但它们在风险评估中的应用却是最近才出现的,并且新的见解和机会仍在不断涌现。为了对该领域提供一些视角,国际生命科学学会风险科学研究所要求一个精选的工作组描述可用于1,3 - 丁二烯、苯和氯乙烯的相关非肿瘤数据,并就这些数据在描述癌症风险方面的实用性发表评论。本文介绍了该工作组的研究结果,并以15条在癌症风险评估中使用非肿瘤数据的简单原则作为结论。